The company launched the "three-year action plan for on-site governance"
Release time:
2021-05-06
2021 , the "three-year action plan for on-site governance" was officially launched a few days ago. three-year action plan for on-site management, that is, starting from
2021, it will take three years to carry out on-site management and transformation and upgrading within the whole company. each enterprise will transform unreasonable sites or the layout of production processes, equipment and facilities by optimizing the design of the plane of the production plant and the space of each production link, to achieve the most concise and reasonable management of 5S ; Through the renovation and upgrading of various production links, the safe, stable, comfortable and healthy production can be realized by eliminating leakage and leakage. Create a standardized site by standardizing on-site visual standards, cleaning standards and greening standards; Through the adoption of new technologies and equipment, the construction of digital and intelligent workshops will be carried out to improve efficiency, reduce production fluctuations and reduce labor intensity of employees, create a safe, green and civilized modern factory with peak cultural characteristics. In order to ensure the effective promotion of the three-year action plan for on-site governance, the company requires each subordinate unit to set up an on-site governance committee with the general manager as the person in charge and the relevant persons in charge of equipment, production, civil engineering, etc. to carry out on-site governance research of the unit, find gaps compared with advanced enterprises, and aim at the weak links of the unit, develop sub-regional and systematic on-site governance plans, objectives to be achieved and annual plans for upgrading and renovation. At present, the work plan to be prepared by each unit is divided into two parts, namely, the overall on-site governance plan and the three-year action upgrading and renovation work plan, which are required to be completed before
530 and submitted to the performance management department of the group company for review. According to the requirements of the company, the overall planning of on-site management of each unit shall at least include the optimization and adjustment of the plane layout of the factory area according to the actual needs, the detailed management of running and leaking points on the production line, the arrangement of equipment, articles and pipelines in workshops, warehouses and various machine rooms, the transformation of road facilities and vehicle parking facilities in the factory area, the anti-corrosion of equipment and facilities and easy-cleaning transformation of various surfaces, environmental protection and safety facilities transformation, intelligent transformation of production and management links, improvement of various signs and building signs, water supply and drainage and greening transformation, etc.; the three-year action improvement and transformation work plan is based on the overall plan, according to the principle of priority, combined with implementation conditions, the annual preparation includes the specific renovation project, the current problems of the proposed renovation project, the preliminary renovation plan and the target reached, the investment cost budget, the general schedule and other contents of the work plan.
It is understood that the annual on-site governance and upgrading action plan will be included in the assessment of the responsibility system of each unit, and the company will assess the completion and effect of the governance projects declared and approved. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page